Home » Newsletters » BioWorld Science

BioWorld Science

Dec. 16, 2021

View Archived Issues

MK2 is a therapeutic target in PDAC that mediates resistance to FIRINOX chemotherapy

Targeting cyclophilin A potentiates chemotherapeutic efficacy in chemoresistant colorectal cancer

YES1 seen to induce the growth of TNBC

Kallyope patents AMPK activators

G1 Therapeutics discloses new CDK2 inhibitors

Senda Biosciences presents AhR antagonists for cancer

Aligos Therapeutics identifies new PD-1/PD-L1 interaction inhibitors

Sinocelltech describes method for enhancing immunogenicitiy of Fc-fusion antigen

Tweaking KLF4 enhances cellular reprogramming

Targeting LIF/LIFR axis as potential therapeutic strategy against adiposity-driven TNBC

HLA-DRB1 copy number predicts response to immunosuppressive therapy in acquired aplastic anemia

One-step synthetic approach for the fabrication of oriented antibody-decorated MOF nanocrystals

Nucleoside analogue sangivamycin shows in vitro activity against several variants of SARS-CoV-2

Discovery of long-acting entecavir prodrugs

BridGene and Peter MacCallum Cancer Centre enter research collaboration for ovarian cancer

GALE is a biomarker of inherited thrombocytopenia

SAB-185 neutralizes SARS-CoV-2 Omicron variant in in vitro pseudovirus model

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...